Total Raised

$20.39M

Investors Count

11

Deal Terms

1

Funding, Valuation & Revenue

9 Fundings

SentryHealth has raised $20.39M over 9 rounds.

SentryHealth's latest funding round was a Acquired for on November 2, 2023.

SentryHealth's 2021 revenue was $1M - $5M. SentryHealth's most recent revenue is from 2021.

Sign up for a free demo to see revenue data from 2021 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/2/2023

Acquired

$XXM

0

FY undefined

2

11/29/2022

Series A - V

$XXM

$XXM

$1M - $5M

FY 2021

10

3/25/2022

Series A - IV

$XXM

$XXM

$X.XXB

((X.XXx))

FY XXXX

10

6/1/2021

Series A - III

$XXM

$XXM

$X.XXB

((X.XXx))

FY XXXX

10

7/10/2018

Series A - II

$XXM

$XXM

0

FY undefined

10

Date

11/2/2023

11/29/2022

3/25/2022

6/1/2021

7/10/2018

Round

Acquired

Series A - V

Series A - IV

Series A - III

Series A - II

Amount

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

$1M - $5M

FY 2021

$X.XXB

((X.XXx))

FY XXXX

$X.XXB

((X.XXx))

FY XXXX

0

FY undefined

Sources

2

10

10

10

10

Start free trial
New call-to-action

SentryHealth Deal Terms

1 Deal Term

SentryHealth's deal structure is available for 1 funding round, including their Series A from October 09, 2015.

Round

Series A

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$XXM

$XXM

$XXM

$XXM

SentryHealth Investors

11 Investors

SentryHealth has 11 investors. First Stop Health invested in SentryHealth's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/2/2023

11/2/2023

1
Acquired

Corporation

Illinois

3/25/2022

11/29/2022

2
Series A - IV, Series A - V (2022)

Venture Capital

Georgia

10/9/2015

7/10/2018

2
Series A, Series A - II (2018)

Venture Capital

Illinois

00/00/0000

00/00/0000

Lunsford Capital

Subscribe to see more

Asset/Investment Management

Kentucky

00/00/0000

00/00/0000

Doug Cobb

Subscribe to see more

Angel Investor (Individual)

First funding

11/2/2023

3/25/2022

10/9/2015

00/00/0000

00/00/0000

Last Funding

11/2/2023

11/29/2022

7/10/2018

00/00/0000

00/00/0000

Investor

Lunsford Capital

Doug Cobb

Rounds

1
Acquired
2
Series A - IV, Series A - V (2022)
2
Series A, Series A - II (2018)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Asset/Investment Management

Angel Investor (Individual)

Location

Illinois

Georgia

Illinois

Kentucky

SentryHealth Acquisitions

2 Acquisitions

SentryHealth acquired 2 companies. Their latest acquisition was WellView Health on March 08, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/8/2022

Series B

$XXM

$5.51M

Merger

1

7/13/2021

Subscribe to see more

$XXM

Subscribe to see more

10

Date

3/8/2022

7/13/2021

Investment Stage

Series B

Companies

Subscribe to see more

Valuation

$XXM

$XXM

Total Funding

$5.51M

Note

Merger

Subscribe to see more

Sources

1

10

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.